Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Intangibles (2016 - 2025)

Haemonetics has reported Intangibles over the past 16 years, most recently at $419.7 million for Q4 2025.

  • For Q4 2025, Intangibles fell 9.85% year-over-year to $419.7 million; the TTM value through Dec 2025 reached $419.7 million, down 9.85%, while the annual FY2025 figure was $455.7 million, 12.22% up from the prior year.
  • Intangibles for Q4 2025 was $419.7 million at Haemonetics, down from $428.4 million in the prior quarter.
  • Over five years, Intangibles peaked at $494.9 million in Q2 2024 and troughed at $250.5 million in Q3 2023.
  • A 5-year average of $370.1 million and a median of $359.6 million in 2021 define the central range for Intangibles.
  • Biggest five-year swings in Intangibles: surged 174.58% in 2021 and later decreased 15.11% in 2022.
  • Year by year, Intangibles stood at $337.2 million in 2021, then fell by 15.68% to $284.4 million in 2022, then soared by 50.95% to $429.3 million in 2023, then rose by 8.47% to $465.6 million in 2024, then dropped by 9.85% to $419.7 million in 2025.
  • Business Quant data shows Intangibles for HAE at $419.7 million in Q4 2025, $428.4 million in Q3 2025, and $450.6 million in Q2 2025.